MiNK Therapeutics (INKT) news
Recent news
Mink Therapeutics to report second quarter 2026 financial results, provide clinical updates on Agent-797 in lung injury, and highlight important business updates
MiNK Therapeutics (NASDAQ: INKT) announced on August 6, 2026, that it will report its second quarter 2026 financial results and provide clinical updates on agenT-797, its lead allogeneic invariant natural killer T (iNKT) cell therapy, in the treatment of acute lung injury . The company will also…
AInvest Wire · Aug 6, 2026Mink Ventures Corporation initiates drill program at Warren Ni Cu Co project; stakes additional claims at its Montcalm Ni Cu Co project; and terminates private placement
Mink Ventures Corporation (TSXV:MINK) has initiated a diamond drill program at its Warren Ni Cu Co project, marking a key step in the company’s exploration strategy for critical minerals. The drilling is expected to evaluate high-priority targets identified following the release of new airborne…
AInvest Wire · Jun 18, 2026ImportantTrump: Will not drop Starlink; calls it good service, will move Tesla around
AInvest Wire · Jun 9, 2025Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.